Search

Sarepta Therapeutics Announces Third Quarter 2019 Financial Results and Recent Corporate Developments
Sarepta Therapeutics to Present at the Credit Suisse 28th Annual Healthcare Conference
Sarepta Corporate Logo
Sarepta Building Exterior
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
How Sarepta infused its corporate brand with urgency and optimism on behalf of patients
Advocacy community unites to support families
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments on February 26, 2020
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference